Innovation and industrial leadership: lessons from pharmaceuticals
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Washington D. C.
Center for Transatlantic Relations
2007
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Item Description: | Includes bibliographical references (p. [211]-223) Executive summary -- Productivity and competitiveness -- Main structural indicators -- R & D and innovation -- Industry structure and competition -- Conclusions |
| Physical Description: | XII, 224 S. Ill. 23cm |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV023322854 | ||
| 003 | DE-604 | ||
| 005 | 20080623 | ||
| 007 | t | ||
| 008 | 080602s2007 a||| |||| 00||| eng d | ||
| 020 | |z 9780978882143 |9 9780978882143 | ||
| 020 | |z 0978882148 |9 0978882148 | ||
| 035 | |a (OCoLC)185690921 | ||
| 035 | |a (DE-599)BVBBV023322854 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a HD9665.5 | |
| 082 | 0 | |a 338.476151 |2 22 | |
| 100 | 1 | |a Pammolli, Fabio |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Innovation and industrial leadership |b lessons from pharmaceuticals |c by Fabio Pammolli and Massimo Riccaboni |
| 264 | 1 | |a Washington D. C. |b Center for Transatlantic Relations |c 2007 | |
| 300 | |a XII, 224 S. |b Ill. |c 23cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. [211]-223) | ||
| 500 | |a Executive summary -- Productivity and competitiveness -- Main structural indicators -- R & D and innovation -- Industry structure and competition -- Conclusions | ||
| 650 | 4 | |a Drug Industry / Europe | |
| 650 | 4 | |a Drug Industry / United States | |
| 650 | 4 | |a Pharmaceutical industry / United States | |
| 650 | 4 | |a Pharmaceutical industry / European Union countries | |
| 650 | 4 | |a Pharmaceutical industry / Asia | |
| 650 | 4 | |a Drug Industry |z Europe | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Pharmaceutical industry |z Asia | |
| 650 | 4 | |a Pharmaceutical industry |z European Union countries | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 651 | 4 | |a Asien | |
| 651 | 4 | |a Europa | |
| 651 | 4 | |a Europäische Union. Mitgliedsstaaten | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Riccaboni, Massimo |e Verfasser |4 aut | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016506919&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016506919 | ||
Record in the Search Index
| _version_ | 1804137662456528896 |
|---|---|
| adam_text | Titel: Innovation and industrial leadership
Autor: Pammolli, Fabio
Jahr: 2007
Table of Contents
Acknowledgements........................................x
Forward................................................xi
Chapter I. Executive Summary.........................1
Chapter II. Productivity and Competitiveness.........13
Main Findings .........................................15
II. 1 Overview .........................................17
11.2 International Comparison of Labor Productivity..........24
11.3 Pharmaceutical Cost Competitiveness ..................29
11.4 Growth Decomposition and Total Factor Productivity.....38
II. 5 The Role of Institutions .............................50
Chapter III. Main Structural Indicators ...............55
Main Findings .........................................57
III.l Overview.........................................59
III.2 Trade, Growth and the Size of the Market ..............60
III. 3 Size, Barriers and the Mystery of Missing Trade ........70
111.4 Trade, Outsourcing and Offshoring....................78
111.5 Size, Internationalization and Competitiveness ..........88
Appendix III. 1 ...................................99
Appendix III.2 Tax Incentives and Foreign
Direct Investment: The Irish Case......105
Chapter IV. R D and Innovation ....................109
Main Findings ........................................111
IV1 Overview........................................113
rV2 Some Plausible Explanations of the
R D Productivity Slowdown........................121
IV3 Global Competition in Pharmaceutical R D...........127
IV.4 The International System of Division of
Innovative Labor..................................141
IV. 5 National Systems of Innovation in Biopharmaceuticals . . .146
Appendix IV....................................157
Part V. Industry Structure and Competition..........159
Main Findings ........................................161
V.l Overview.........................................163
V.2 The Determinants of Market Growth..................165
V.3 Market Competition................................173
Appendix V.l ...................................195
Appendix V.2 Market Regulation, Innovation
and Competition.....................196
Part VI. Conclusions .................................203
References.............................................211
About the Authors.......................................224
|
| adam_txt |
Titel: Innovation and industrial leadership
Autor: Pammolli, Fabio
Jahr: 2007
Table of Contents
Acknowledgements.x
Forward.xi
Chapter I. Executive Summary.1
Chapter II. Productivity and Competitiveness.13
Main Findings .15
II. 1 Overview .17
11.2 International Comparison of Labor Productivity.24
11.3 Pharmaceutical Cost Competitiveness .29
11.4 Growth Decomposition and Total Factor Productivity.38
II. 5 The Role of Institutions .50
Chapter III. Main Structural Indicators .55
Main Findings .57
III.l Overview.59
III.2 Trade, Growth and the Size of the Market .60
III. 3 Size, Barriers and "the Mystery of Missing Trade".70
111.4 Trade, Outsourcing and Offshoring.78
111.5 Size, Internationalization and Competitiveness .88
Appendix III. 1 .99
Appendix III.2 Tax Incentives and Foreign
Direct Investment: The Irish Case.105
Chapter IV. R D and Innovation .109
Main Findings .111
IV1 Overview.113
rV2 Some Plausible Explanations of the
R D Productivity Slowdown.121
IV3 Global Competition in Pharmaceutical R D.127
IV.4 The International System of Division of
Innovative Labor.141
IV. 5 National Systems of Innovation in Biopharmaceuticals . . .146
Appendix IV.157
Part V. Industry Structure and Competition.159
Main Findings .161
V.l Overview.163
V.2 The Determinants of Market Growth.165
V.3 Market Competition.173
Appendix V.l .195
Appendix V.2 Market Regulation, Innovation
and Competition.196
Part VI. Conclusions .203
References.211
About the Authors.224 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Pammolli, Fabio Riccaboni, Massimo |
| author_facet | Pammolli, Fabio Riccaboni, Massimo |
| author_role | aut aut |
| author_sort | Pammolli, Fabio |
| author_variant | f p fp m r mr |
| building | Verbundindex |
| bvnumber | BV023322854 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 |
| callnumber-search | HD9665.5 |
| callnumber-sort | HD 49665.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)185690921 (DE-599)BVBBV023322854 |
| dewey-full | 338.476151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.476151 |
| dewey-search | 338.476151 |
| dewey-sort | 3338.476151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02048nam a2200505 c 4500</leader><controlfield tag="001">BV023322854</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080623 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080602s2007 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780978882143</subfield><subfield code="9">9780978882143</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0978882148</subfield><subfield code="9">0978882148</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)185690921</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023322854</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.476151</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pammolli, Fabio</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Innovation and industrial leadership</subfield><subfield code="b">lessons from pharmaceuticals</subfield><subfield code="c">by Fabio Pammolli and Massimo Riccaboni</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington D. C.</subfield><subfield code="b">Center for Transatlantic Relations</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 224 S.</subfield><subfield code="b">Ill.</subfield><subfield code="c">23cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. [211]-223)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Executive summary -- Productivity and competitiveness -- Main structural indicators -- R & D and innovation -- Industry structure and competition -- Conclusions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Asia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">Europe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">Asia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Asien</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europa</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Union. Mitgliedsstaaten</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riccaboni, Massimo</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016506919&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016506919</subfield></datafield></record></collection> |
| geographic | Asien Europa Europäische Union. Mitgliedsstaaten USA |
| geographic_facet | Asien Europa Europäische Union. Mitgliedsstaaten USA |
| id | DE-604.BV023322854 |
| illustrated | Illustrated |
| index_date | 2024-07-02T20:54:24Z |
| indexdate | 2024-07-09T21:15:51Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016506919 |
| oclc_num | 185690921 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XII, 224 S. Ill. 23cm |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Center for Transatlantic Relations |
| record_format | marc |
| spelling | Pammolli, Fabio Verfasser aut Innovation and industrial leadership lessons from pharmaceuticals by Fabio Pammolli and Massimo Riccaboni Washington D. C. Center for Transatlantic Relations 2007 XII, 224 S. Ill. 23cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references (p. [211]-223) Executive summary -- Productivity and competitiveness -- Main structural indicators -- R & D and innovation -- Industry structure and competition -- Conclusions Drug Industry / Europe Drug Industry / United States Pharmaceutical industry / United States Pharmaceutical industry / European Union countries Pharmaceutical industry / Asia Drug Industry Europe Drug Industry United States Pharmaceutical industry Asia Pharmaceutical industry European Union countries Pharmaceutical industry United States Asien Europa Europäische Union. Mitgliedsstaaten USA Riccaboni, Massimo Verfasser aut HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016506919&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Pammolli, Fabio Riccaboni, Massimo Innovation and industrial leadership lessons from pharmaceuticals Drug Industry / Europe Drug Industry / United States Pharmaceutical industry / United States Pharmaceutical industry / European Union countries Pharmaceutical industry / Asia Drug Industry Europe Drug Industry United States Pharmaceutical industry Asia Pharmaceutical industry European Union countries Pharmaceutical industry United States |
| title | Innovation and industrial leadership lessons from pharmaceuticals |
| title_auth | Innovation and industrial leadership lessons from pharmaceuticals |
| title_exact_search | Innovation and industrial leadership lessons from pharmaceuticals |
| title_exact_search_txtP | Innovation and industrial leadership lessons from pharmaceuticals |
| title_full | Innovation and industrial leadership lessons from pharmaceuticals by Fabio Pammolli and Massimo Riccaboni |
| title_fullStr | Innovation and industrial leadership lessons from pharmaceuticals by Fabio Pammolli and Massimo Riccaboni |
| title_full_unstemmed | Innovation and industrial leadership lessons from pharmaceuticals by Fabio Pammolli and Massimo Riccaboni |
| title_short | Innovation and industrial leadership |
| title_sort | innovation and industrial leadership lessons from pharmaceuticals |
| title_sub | lessons from pharmaceuticals |
| topic | Drug Industry / Europe Drug Industry / United States Pharmaceutical industry / United States Pharmaceutical industry / European Union countries Pharmaceutical industry / Asia Drug Industry Europe Drug Industry United States Pharmaceutical industry Asia Pharmaceutical industry European Union countries Pharmaceutical industry United States |
| topic_facet | Drug Industry / Europe Drug Industry / United States Pharmaceutical industry / United States Pharmaceutical industry / European Union countries Pharmaceutical industry / Asia Drug Industry Europe Drug Industry United States Pharmaceutical industry Asia Pharmaceutical industry European Union countries Pharmaceutical industry United States Asien Europa Europäische Union. Mitgliedsstaaten USA |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016506919&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT pammollifabio innovationandindustrialleadershiplessonsfrompharmaceuticals AT riccabonimassimo innovationandindustrialleadershiplessonsfrompharmaceuticals |